Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 419
Filter
1.
Res Vet Sci ; 152: 537-545, 2022 Dec 20.
Article in English | MEDLINE | ID: mdl-36179547

ABSTRACT

Antibiotic administration is crucial to ensure the health and productivity of dairy cattle. Mastitis is a disease that is typically a result of an intramammary infection (IMI), and antibiotic regimens are implemented to aid in curing IMI. Diagnosis is usually by detection of elevated milk somatic cell counts (SCC) and/or presence of culturable pathogens in the milk. Antibiotic treatment success is associated with the SCC at the time of treatment, though this correlation is still poorly understood. The objective of this project was to evaluate pre-treatment SCC and its association with IMI cure incidence following a standard antibiotic treatment. We hypothesized that pre-treatment SCC would be significantly lower in cases where the IMI ultimately cured compared to cases where the IMI failed to cure. Milk samples were collected aseptically from lactating cow quarters experiencing clinical or subclinical mastitis (n = 52). Clinical mastitis was diagnosed by a trained milking technician and subclinical mastitis was diagnosed at the quarter level as a SCC > 200,000 cells/mL and presence of bacterical growth in milk at time of treatment. After collection of the day 0 (D0) milk samples, the SCC was enumerated, and the milk sample cultured. Intramammary antibiotic therapy Cetftiofur hydrochloride (Spectramast® LC) was administered once/day for 5 days. Post-treatment samples were collected 14 d (D14) and 28 d (D28) later. A bacteriological cure was confirmed when both the D14 and D28 samples were free of culturable pathogens. The overall cure rate was 46.2%. Interestingly, the cure rates of antibiotic therapy decreased as pre-treatment SCC increased. Quarters that experienced bacteriological cure demonstrated a lower pre-treatment SCC (507,041 cells/mL ± 127.86 SEM, P = 0.01) compared to cows that did not cure, which had high pre-treatment SCC (1,640,392 cells/mL ± 333.28 SEM). Quarters that failed to cure had higher SCC values 28 days post-treatment in comparison to quarters that cured (P < 0.001). Future studies should investigate whether we can develop unique SCC-dependent mastitis treatment protocols which increase mastitis cure rates and enhance overall mammary health.


Subject(s)
Cattle Diseases , Mastitis, Bovine , Cattle , Animals , Female , Mastitis, Bovine/diagnosis , Mastitis, Bovine/drug therapy , Mastitis, Bovine/epidemiology , Lactation , Mammary Glands, Animal , Cell Count/veterinary , Milk , Anti-Bacterial Agents/therapeutic use , Cattle Diseases/drug therapy
2.
J Mol Biol ; 313(1): 35-48, 2001 Oct 12.
Article in English | MEDLINE | ID: mdl-11601845

ABSTRACT

The 30 S ribosomal subunit assembles in vitro through the hierarchical binding of 21 ribosomal proteins to 16 S rRNA. The central domain of 16 S rRNA becomes the platform of the 30 S subunit upon binding of ribosomal proteins S6, S8, S11, S15, S18 and S21. The assembly of the platform is nucleated by binding of S15 to 16 S rRNA, followed by the cooperative binding of S6 and S18. The prior binding of S6 and S18 is required for binding of S11 and S21. We have studied the mechanism of the cooperative binding of S6 and S18 to the S15-rRNA complex by isothermal titration calorimetry and gel mobility shift assays with rRNA and proteins from the hyperthermophilic bacterium Aquifex aeolicus. S6 and S18 form a stable heterodimer in solution with an apparent dissociation constant of 8.7 nM at 40 degrees C. The S6:S18 heterodimer binds to the S15-rRNA complex with an equilibrium dissociation constant of 2.7 nM at 40 degrees C. Consistent with previous studies using rRNA and proteins from Escherichia coli, we observed no binding of S6 or S18 in the absence of the other protein or S15. The presence of S15 increases the affinity of S6:S18 for the RNA by at least four orders of magnitude. The kinetics of S6:S18 binding to the S15-rRNA complex are slow, with an apparent bimolecular rate constant of 8.0 x 10(4) M(-1) s(-1) and an apparent unimolecular dissociation rate of 1.6 x 10(-4) s(-1). These results, which are consistent with a model in which S6 and S18 bind as a heterodimer to the S15-rRNA complex, provide a mechanistic framework to describe the previously observed S15-mediated cooperative binding of S6 and S18 in the ordered assembly of a multi-protein ribonucleoprotein complex.


Subject(s)
Bacteria , RNA, Ribosomal, 16S/metabolism , Ribosomal Proteins/metabolism , Ribosomes/chemistry , Ribosomes/metabolism , Bacteria/chemistry , Bacteria/genetics , Bacteria/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Base Sequence , Calorimetry , Dimerization , Escherichia coli Proteins/metabolism , Kinetics , Macromolecular Substances , Protein Binding , Protein Structure, Tertiary , Protein Subunits , RNA, Ribosomal, 16S/chemistry , RNA, Ribosomal, 16S/genetics , Ribosomal Protein S6 , Ribosomal Proteins/chemistry , Ribosomes/genetics , Thermodynamics
3.
Microcirculation ; 8(4): 251-63, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11528533

ABSTRACT

OBJECTIVE: These experiments were designed to elucidate mechanisms mediating vascular dysfunction induced by advanced glycation end products (AGEs). METHODS: Skin chambers were mounted on the backs of Sprague-Dawley rats and 1 week later, granulation tissue that formed in the bottom of the chamber was exposed twice daily for 7 days to glycated rat serum albumin in the presence and absence of inhibitors of reactive oxygen intermediates, nitric oxide synthase and guanylate cyclase, protein kinase C (PKC), and a neutralizing vascular endothelial growth factor (VEGF) antibody. Vascular (125)I-albumin clearance and blood flow were quantified by use of a double isotope-dilution technique and radiolabeled microspheres, respectively. RESULTS: Albumin permeation and blood flow were increased dose-dependently to a maximum of 2 to 3 times controls by increasing the extent of glucose modification, the concentration, or the duration of exposure to glycated albumin. These increases were significantly attenuated by probucol and superoxide dismutase; N(G)-nitro-L-arginine-methyl ester (L-NAME), a nitric oxide synthase inhibitor; LY83583, a guanylate cyclase inhibitor; and LY333531, a beta-isoform-selective protein kinase C inhibitor. A neutralizing VEGF monoclonal antibody also markedly attenuated the permeability and blood flow increases induced by glycated albumin. CONCLUSIONS: These observations indicate potentially important roles for oxygen free-radicals and nitric oxide in mediating permeability and blood flow changes induced by glycated proteins via mechanisms involving increased protein kinase C activity and VEGF production. Striking similarities in the mechanism by which hyperglycemia and glycated proteins induce vascular dysfunction suggest that a common pathway mediates effects of these different metabolic imbalances on vascular dysfunction.


Subject(s)
Endothelial Growth Factors/pharmacology , Glycation End Products, Advanced/pharmacology , Lymphokines/pharmacology , Vascular Diseases/chemically induced , Animals , Antioxidants/pharmacology , Capillary Permeability/drug effects , Glycation End Products, Advanced/physiology , Granulation Tissue/blood supply , Guanylate Cyclase/antagonists & inhibitors , Guanylate Cyclase/pharmacology , Guanylate Cyclase/physiology , Male , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/pharmacology , Protein Kinase C/physiology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/pharmacology , Regional Blood Flow/drug effects , Serum Albumin/metabolism , Vascular Diseases/metabolism , Vascular Diseases/physiopathology , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors , Glycated Serum Albumin
4.
J Cell Biochem ; 82(4): 556-65, 2001.
Article in English | MEDLINE | ID: mdl-11500933

ABSTRACT

p38 MAP kinases (p38) and c-Jun N-terminal protein kinases (JNK) have been associated with TNF-alpha-induced apoptosis. However, recent studies indicate that an early but brief activation of JNK and/or p38 may actually protect some cells from TNF-alpha-induced apoptosis. Whether the activation of JNK and p38 provides a pro- or anti-apoptotic signal for TNF-alpha has been controversial. In this study, we investigated the role of p38 in the regulation of TNF-alpha cytotoxicity in rat mesangial cells. Treatment of the cells with TNF-alpha alone had little effect on their viability, but they became very sensitive to apoptosis when treated with TNF-alpha in the presence of the p38 inhibitor SB 203580. These results suggested that the p38 pathway is critical for mesangial cells to survive the toxic effect of TNF-alpha. Using adenovirus-mediated gene transfer technique, we further demonstrated that p38beta, but not p38alpha, is essential to protect the cells from TNF-alpha toxicity. It has been speculated that there is a synergetic interaction between the p38 and the nuclear factor-kappaB (NF-kappaB) pathways in protecting certain cells from apoptosis. However, expression of neither p38beta nor its dominant negative mutant in mesangial cells interfered with TNF-alpha-induced translocation of NF-kappaB, the initial step of NF-kappaB activation. While it is unclear whether p38beta regulates NF-kappaB transcription activity at other steps, it is apparent that p38beta does not affect TNF-alpha-induced NF-kappaB activation at the stage of nuclear translocation.


Subject(s)
Apoptosis , Glomerular Mesangium/cytology , Mitogen-Activated Protein Kinases/physiology , Tumor Necrosis Factor-alpha/pharmacology , Adenoviridae/genetics , Animals , Cell Survival , Cells, Cultured , Enzyme Inhibitors/pharmacology , Genetic Vectors , Glomerular Mesangium/metabolism , Imidazoles/pharmacology , Male , Mitogen-Activated Protein Kinase 11 , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Mutation , NF-kappa B/metabolism , Pyridines/pharmacology , Rats , Rats, Sprague-Dawley , Transfection , p38 Mitogen-Activated Protein Kinases
7.
Curr Opin Struct Biol ; 11(3): 309-14, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11406379

ABSTRACT

Large RNAs often have rugged folding energy landscapes that result in severe misfolding and slow folding kinetics. Several interdependent parameters that contribute to misfolding are now well understood and examples of large RNAs and ribonucleoproteins that avoid kinetic traps have been reported. These advances have facilitated the exploration of fundamental RNA folding processes that were previously inaccessible.


Subject(s)
RNA/chemistry , Exons , Kinetics , Nucleic Acid Conformation , RNA/metabolism , Ribonucleoproteins/chemistry , Ribonucleoproteins/metabolism
9.
Neural Comput ; 13(3): 563-93, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11244556

ABSTRACT

This article proposes a neural network model of supervised learning that employs biologically motivated constraints of using local, on-line, constructive learning. The model possesses two novel learning mechanisms. The first is a network for learning topographic mixtures. The network's internal category nodes are the mixture components, which learn to encode smooth distributions in the input space by taking advantage of topography in the input feature maps. The second mechanism is an attentional biasing feedback circuit. When the network makes an incorrect output prediction, this feedback circuit modulates the learning rates of the category nodes, by amounts based on the sharpness of their tuning, in order to improve the network's prediction accuracy. The network is evaluated on several standard classification benchmarks and shown to perform well in comparison to other classifiers.


Subject(s)
Attention/physiology , Neural Networks, Computer , Visual Pathways/physiology , Brain Mapping , Computer Simulation , Feedback , Humans
10.
Cereb Cortex ; 11(1): 37-58, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11113034

ABSTRACT

A neural model suggests how horizontal and interlaminar connections in visual cortical areas V1 and V2 develop within a laminar cortical architecture and give rise to adult visual percepts. The model suggests how mechanisms that control cortical development in the infant lead to properties of adult cortical anatomy, neurophysiology and visual perception. The model clarifies how excitatory and inhibitory connections can develop stably by maintaining a balance between excitation and inhibition. The growth of long-range excitatory horizontal connections between layer 2/3 pyramidal cells is balanced against that of short-range disynaptic interneuronal connections. The growth of excitatory on-center connections from layer 6-to-4 is balanced against that of inhibitory interneuronal off-surround connections. These balanced connections interact via intracortical and intercortical feedback to realize properties of perceptual grouping, attention and perceptual learning in the adult, and help to explain the observed variability in the number and temporal distribution of spikes emitted by cortical neurons. The model replicates cortical point spread functions and psychophysical data on the strength of real and illusory contours. The on-center, off-surround layer 6-to-4 circuit enables top-down attentional signals from area V2 to modulate, or attentionally prime, layer 4 cells in area V1 without fully activating them. This modulatory circuit also enables adult perceptual learning within cortical area V1 and V2 to proceed in a stable way.


Subject(s)
Geniculate Bodies/physiology , Models, Neurological , Neocortex/physiology , Pyramidal Cells/physiology , Vision, Ocular/physiology , Visual Cortex/physiology , Animals , Humans
11.
J Mol Biol ; 305(1): 11-21, 2001 Jan 05.
Article in English | MEDLINE | ID: mdl-11114243

ABSTRACT

The free energy landscape for the folding of large, multidomain RNAs is rugged, and kinetically trapped, misfolded intermediates are a hallmark of RNA folding reactions. Here, we examine the role of a native loop-receptor interaction in determining the ruggedness of the energy landscape for folding of the Tetrahymena ribozyme. We demonstrate a progressive smoothing of the energy landscape for ribozyme folding as the strength of the loop-receptor interaction is reduced. Remarkably, with the most severe mutation, global folding is more rapid than for the wild-type ribozyme and proceeds in a concerted fashion without the accumulation of long-lived kinetic intermediates. The results demonstrate that a complex interplay between native tertiary interactions, divalent ion concentration, and non-native secondary structure determines the ruggedness of the energy landscape. Furthermore, the results suggest that kinetic folding transitions involving large regions of highly structured RNAs can proceed in a concerted fashion, in the absence of significant stable, preorganized tertiary structure.


Subject(s)
Nucleic Acid Conformation , RNA Stability/genetics , RNA, Catalytic/chemistry , RNA, Catalytic/metabolism , Tetrahymena/genetics , Animals , Base Pairing/genetics , Base Sequence , Binding Sites , Cations, Divalent/metabolism , Kinetics , Magnesium/metabolism , Models, Chemical , Mutation/genetics , Nucleic Acid Hybridization , Oligoribonucleotides/chemistry , Oligoribonucleotides/genetics , Oligoribonucleotides/metabolism , RNA, Catalytic/genetics , Thermodynamics
12.
Curr Protoc Nucleic Acid Chem ; Chapter 7: Unit 7.7, 2001 May.
Article in English | MEDLINE | ID: mdl-18428875

ABSTRACT

Despite recent advances in the solution of NMR structures of RNA and RNA-ligand complexes, the rate limiting step remains the gathering of a large number of NOE and torsion restraints. Additional sources of information for structure determination of larger RNA molecules have recently become available, and it is possible to supplement NOE and J-coupling data with the measurement of dipolar couplings and cross-correlated relaxation rates in high-resolution NMR spectroscopy.


Subject(s)
Nuclear Magnetic Resonance, Biomolecular/methods , Nucleic Acid Conformation , RNA/chemistry , Base Sequence , Hydrogen Bonding , Isotope Labeling , Molecular Sequence Data , RNA/genetics
14.
J Neuropathol Exp Neurol ; 60(12): 1153-69, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11764088

ABSTRACT

We have developed an animal model of diabetic autonomic neuropathy that is characterized by neuroaxonal dystrophy (NAD) involving ileal mesenteric nerves and prevertebral sympathetic superior mesenteric ganglia (SMG) in chronic streptozotocin (STZ)-diabetic rats. Studies with the sorbitol dehydrogenase inhibitor SDI-158, which interrupts the conversion of sorbitol to fructose (and reactions dependent on the second step of the sorbitol pathway), have shown a dramatically increased frequency of NAD in ileal mesenteric nerves and SMG of SDI-treated versus untreated diabetics. Although lesions developed prematurely and in greater numbers in SDI-treated diabetics, their distinctive ultrastructural appearance was identical to that previously reported in long-term untreated diabetics. An SDI effect was first demonstrated in the SMG of rats that were diabetic for as little as 5 wk and was maintained for at least 7.5 months. As in untreated diabetic rats, rats treated with SDI i) showed involvement of lengthy ileal, but not shorter, jejunal mesenteric nerves; ii) demonstrated NAD in paravascular mesenteric nerves distributed to myenteric ganglia while sparing adjacent perivascular axons ramifying within the vascular adventitia; and, iii) failed to develop NAD in the superior cervical ganglia (SCG). After only 2 months of SDI-treatment, tyrosine hydroxylase immunolocalization demonstrated marked dilatation of postganglionic noradrenergic axons in paravascular ileal mesenteric nerves and within the gut wall versus those innervating extramural mesenteric vasculature. The effect of SDI on diabetic NAD in SMG was completely prevented by concomitant administration of the aldose reductase inhibitor Sorbinil. Treatment of diabetic rats with Sorbinil also prevented NAD in diabetic rats not treated with SDI. These findings indicate that sorbitol pathway-linked metabolic imbalances play a critical role in the development of NAD in this model of diabetic sympathetic autonomic neuropathy.


Subject(s)
Diabetes Mellitus, Experimental/enzymology , Diabetic Neuropathies/enzymology , L-Iditol 2-Dehydrogenase/antagonists & inhibitors , Animals , Anti-Bacterial Agents , Diabetes Mellitus, Experimental/pathology , Diabetic Neuropathies/pathology , Enzyme Inhibitors/pharmacology , Ganglia, Sympathetic/enzymology , Ganglia, Sympathetic/pathology , Ganglia, Sympathetic/ultrastructure , L-Iditol 2-Dehydrogenase/metabolism , Male , Pyrimidines/pharmacology , Rats , Rats, Sprague-Dawley , Sciatic Nerve/enzymology , Sciatic Nerve/pathology , Sciatic Nerve/ultrastructure , Streptozocin
15.
J Mol Biol ; 314(3): 413-22, 2001 Nov 30.
Article in English | MEDLINE | ID: mdl-11846555

ABSTRACT

The Bacillus stearothermophilus ribosomal protein S15 (BS15) binds both a three-helix junction in the central domain of 16 S ribosomal RNA and its cognate mRNA. Native gel mobility-shift assays show that BS15 interacts specifically and with high affinity to the 5'-untranslated region (5'-UTR) of this cognate mRNA with an apparent dissociation constant of 3(+/-0.3) nM. In order to localize the structural elements that are essential for BS15 recognition, a series of deletion mutants of the full cognate mRNA were prepared and tested in the same gel-shift assay. The minimal binding site for BS15 is a 50 nucleotide RNA showing a close secondary structure resemblance to the BS15 binding region from 16 S rRNA. There are two major structural motifs that must be maintained for high-affinity binding. The first being a purine-rich three-helix junction, and the second being an internal loop. The sequence identity of the internal loops differs greatly between the BS15 mRNA and rRNA sites, and this difference is correlated to discrimination between wild-type BS15 and a BS15(H45R) mutant. The association and dissociation kinetics measured for the 5'-UTR-BS15 interaction are quite slow, but are typical for a ribosomal protein-RNA interaction. The BS15 mRNA and 16 S rRNA binding sites share a common secondary structure yet have little sequence identity. The mRNA and rRNA may in fact present similar if not identical structural elements that confer BS15 recognition.


Subject(s)
5' Untranslated Regions/metabolism , Geobacillus stearothermophilus/genetics , Operator Regions, Genetic/genetics , Protein Biosynthesis/genetics , RNA, Bacterial/metabolism , RNA-Binding Proteins/metabolism , Ribosomal Proteins/metabolism , 5' Untranslated Regions/chemistry , 5' Untranslated Regions/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Electrophoretic Mobility Shift Assay , Geobacillus stearothermophilus/metabolism , Kinetics , Models, Molecular , Molecular Sequence Data , Mutation/genetics , Nucleic Acid Conformation , RNA, Bacterial/chemistry , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/chemistry , RNA, Ribosomal, 16S/genetics , RNA, Ribosomal, 16S/metabolism , RNA-Binding Proteins/isolation & purification , Ribosomal Proteins/isolation & purification , Substrate Specificity , Titrimetry
17.
Nat Struct Biol ; 7(10): 834-7, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11017187

ABSTRACT

Two generalizations can be drawn from the recent rapid progress in understanding RNA-protein interactions. First, there is a great diversity of observed protein and RNA structural motifs. Second, formation of almost every RNA-protein complex that has been characterized involves conformational changes in the protein, the RNA, or both. The role of these conformational changes in the biological function of RNA-protein complexes is not at all clear. Whether or not conformational changes are a critical feature of ribonucleoprotein complex assembly or are an unimportant mechanistic detail, the ubiquity of these changes warrants careful consideration of their implications.


Subject(s)
RNA-Binding Proteins/metabolism , RNA/metabolism , Molecular Structure , Protein Binding , Protein Folding , RNA/chemistry , RNA-Binding Proteins/chemistry , Ribosomal Proteins/chemistry , Ribosomal Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...